Febuxostat vs allopurinol: real-world cardiovascular safety

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1762卷 / 1期
关键词：
D O I：
10.1007/s40278-019-64745-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [1] Febuxostat vs allopurinol for gout: cardiovascular safety
    [J]. Reactions Weekly, 2021, 1858 (1) : 9 - 9
  • [2] Cardiovascular safety assessment of febuxostat and allopurinol in the real world: A retrospective cohort study
    Hung, Pei-Yuan
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 159 - 159
  • [3] Cardiovascular Safety of Febuxostat Versus Allopurinol in the Real World: Old Reliable Comes Out on Top
    Mankad, Rekha
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1128 - 1130
  • [4] Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
    Su, Ching-Yen
    Shen, Li-Jiuan
    Hsieh, Song-Chou
    Lin, Lian-Yu
    Lin, Fang-Ju
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1147 - 1157
  • [5] Characteristics of Febuxostat and Allopurinol Initiators and Utilization Patterns in Real-World Settings
    Bradley, Marie
    Eworuke, Efe
    Cosgrove, Austin
    Hou, Laura
    Toh, Darren
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 35 - 36
  • [6] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    [J]. INTERNIST, 2020, 61 (05): : 530 - 532
  • [7] Serum Urate-Lowering Effectiveness of Febuxostat Compared with Allopurinol and Switching to Febuxostat From Allopurinol In the Real-World Setting.
    Pandya, Bhavik J.
    Pinsky, Brett W.
    Rey, Gabriel Gomez
    Singh, Jasvinder A.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S350 - S350
  • [8] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1200 - 1210
  • [9] A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database
    Altan, Aylin
    Shiozawa, Aki
    Bancroft, Tim
    Singh, Jasvinder A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2015, 21 (08) : 411 - 418
  • [10] CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
    White, William B.
    Chohan, Saima
    Dabholkar, Aruna
    Hunt, Barbara
    Jackson, Robert
    [J]. AMERICAN HEART JOURNAL, 2012, 164 (01) : 14 - 20
12345